Filter
1256
Text search:
inventory
Featured
139
386
Language
Document type
721
199
134
106
54
17
15
7
1
1
1
Countries
64
59
49
36
32
32
31
31
31
27
26
26
20
18
16
16
14
14
14
14
13
12
11
9
9
9
9
8
8
8
7
7
6
5
5
5
5
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
543
93
57
56
41
26
21
Toolboxes
116
80
61
61
52
46
39
33
30
27
26
24
21
21
17
17
15
13
13
12
9
7
6
5
5
1
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
This compendium collates current tools and resources on quality improvement developed by the WHO Service Delivery and Safety Department and provides examples of how the tools and resources have been applied in country settings. The target audience for this document are ministries of health, facility
...
Arq Neuropsiquiatr 2011;69(2-B):342-348
Perspectives on Drugs
Harm reduction: evidence, impacts and challenges
-10-
The Facilitator's Guide has been piloted in Borno (Nigeria) and in Fafan zone (Somali region, Ethiopia) and improved iteratively after each test.
What does the ROAP have that you won't find in other methodologies?
It is based on holistic, people-centred approaches that span across sectors an
...
Introduction
Chapter A.4
2017 edition
Introduction
Chapter A.6
Introduction
Chapter A.7
Introduction
Chapter A.9
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o
...
Externalising disorders
Chapter D.2
Mood disorders
Chapter E.2
Anxiety disorders
Chapter F.1
2018 edition
Anxiety disorders
Chapter F.2
Anxiety disorders
Chapter F.5
Other disorders Chapter H.1
Other disorders
Chapter H.3
